Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Could SHIB Be the Next in Line After PEPE Delivered 178%?

Could SHIB Be the Next in Line After PEPE Delivered 178%?

CoineditionCoinedition2024/02/29 09:34
By:Victor Olanrewaju

After making millions of gains from PEPE, a whale decided to SHIB. The AO, alongside the Supertrend, supported SHIB’s rise to $0.000015. Capital rotation and profit-taking could drive PEPE down to $0.0000027.

  • After making millions of gains from PEPE, a whale decided to SHIB.
  • The AO, alongside the Supertrend, supported SHIB’s rise to $0.000015.
  • Capital rotation and profit-taking could drive PEPE down to $0.0000027.

According to Spot On Chain, a whale made $3.47 million from Pepe (PEPE) after the meme coin hit an all-time high (ATH). Spot On Chain noted that the whale deposited all the 1.97 trillion PEPE tokens he owned to Binance, as gains on the holdings had increased by 135%.

But after depositing the tokens, the whale bought 75.91 billion Shiba Inu (SHIB) tokens and withdrew them from Binance.

After $PEPE reached new ATH, smart whale 0x37d deposited all 1.97T $PEPE ($6.06M) to #Binance ~7hrs ago, making $3.47M (+135%) if truly selling.

Moreover, the whale withdrew 75.91B $SHIB ($893K) from #Binance for the first time ~1hr ago. Bullish for a $SHIB pump soon? 🤔

Follow… pic.twitter.com/dEX9SgQXrR

— Spot On Chain (@spotonchain) February 29, 2024

PEPE’s price jumped by 182% in the last seven days. Within the same period, Shiba Inu’s price increased by 39.14%, CoinMarketCap showed .

Shiba Inu (SHIB) Price Analysis

SHIB exited its long-standing consolidating phase after bulls capitalized on the $0.00000942 support. Buying pressure was enough to raise SHIB’s price to the $0.000011 region. However, the token encountered a minor resistance at $0.00001134.

But with bulls all over the price action, SHIB breached the hurdle. Signals from the 4-hour chart showed that the Supertrend indicator flashed a buy signal at $0.000010. This was because the green segment of the indicator had overshadowed the red area.

At press time, SHIB’s price was $0.00001359. Coin Edition also looked at the Awesome Oscillator (AO), whose reading was positive. The AO reading suggests increasing upward momentum, which could drive higher prices.

Could SHIB Be the Next in Line After PEPE Delivered 178%? image 0 Could SHIB Be the Next in Line After PEPE Delivered 178%? image 1 SHIB/USD 4-Hour Chart (Source: TradingView )

From a bullish perspective, SHIB’s price could extend to $0.000015 in the short term. However, if traders decide to book some profits, the price might decline. In the long run, SHIB could replicate PEPE’s performance, but it is not guaranteed to happen within a week.

Pepe (PEPE) Price Analysis

The PEPE/USD 4-hour chart displayed a market structure similar to SHIB’s. However, the difference was that PEPE’s attempt at another high has been rejected. PEPE’s price had initially tapped $0.0000035. 

But a quick rejection sent the value back to $0.0000031. At press time, the Relative Strength Index (RSI) was 77.42, indicating that the token was overbought. In a situation like this, PEPE’s price might decrease.

Could SHIB Be the Next in Line After PEPE Delivered 178%? image 2 Could SHIB Be the Next in Line After PEPE Delivered 178%? image 3 PEPE/USD 4-Hour Chart (Source: TradingView )

A look at the 0.382 Fibonacci retracement showed that PEPE could slide to $0.0000027. If the token erases the gains, traders can try to buy at a discount, which could propel the price higher. However, an increase in capital rotation like the whale has done with SHIB could invalidate the bullish thesis.

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market